Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Midazolam Maleate
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Neuraxpharm
Deal Size : Undisclosed
Deal Type : Acquisition
Neuraxpharm Expands Its Business in Southeast Europe
Details : Having acquired Brain Therapeutics, Neuraxpharm is now able to bring new products to the Greek market including the market-leading product for emergency treatment of children and adolescents with epilepsy, Buccolam®, will be among the products to be off...
Product Name : Buccolam
Product Type : Miscellaneous
Upfront Cash : Undisclosed
March 08, 2022
Lead Product(s) : Midazolam Maleate
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Neuraxpharm
Deal Size : Undisclosed
Deal Type : Acquisition
Reset All
